Arrowhead reports promising obesity treatment data
PASADENA, Calif. - Arrowhead Pharmaceuticals, Inc. (NASDAQ: NASDAQ:ARWR) today shared preclinical study outcomes for ARO-INHBE, a potential new treatment for obesity and metabolic diseases, at the Am… [+4867 chars]